Literature DB >> 18031860

Synthesis and characterization of poly(2-ethyl 2-oxazoline)-conjugates with proteins and drugs: suitable alternatives to PEG-conjugates?

Anna Mero1, Gianfranco Pasut, Lisa Dalla Via, Martin W M Fijten, Ulrich S Schubert, Richard Hoogenboom, Francesco M Veronese.   

Abstract

Poly(2-ethyl-2-oxazoline) (POZ) was synthesized by living cationic ring-opening polymerization under microwave irradiation yielding polymers with low polydispersity indices (PDI, 1.15). The polymerization was quenched with sodium carbonate yielding a hydroxyl end-group with a high degree of functionality. The hydroxyl group was converted to carboxylate and the polymer was purified by ionic exchange chromatography. Following activation to succinimidyl ester, POZ-conjugates to high and low molecular weight biomolecules, trypsin and Ara-C, were obtained. The properties of the conjugates were compared to those of the corresponding conjugates with poly(ethylene glycol) (PEG) of similar size. The coupling of POZ to trypsin did not affect the enzymatic activity towards low mass substrates but, on the contrary, reduced the activity on the higher mass ones. Furthermore, the POZ-protein conjugates showed hydrodynamic volumes and protein rejecting properties similar to those of PEG-conjugates. Similarly, the POZ-Ara-C conjugate revealed a drug release profile, stability towards the degrading enzyme cytidine deaminase and in vitro cytotoxicity comparable to what has already been described for the PEG derivative. These data support the potential of POZ as a versatile alternative to the well-known and widely used PEG for protein and drug conjugation and delivery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18031860     DOI: 10.1016/j.jconrel.2007.10.010

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  18 in total

1.  Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles.

Authors:  Robert Luxenhofer; Gaurav Sahay; Anita Schulz; Daria Alakhova; Tatiana K Bronich; Rainer Jordan; Alexander V Kabanov
Journal:  J Control Release       Date:  2011-04-13       Impact factor: 9.776

2.  Study of the potential of amphiphilic conetworks based on poly(2-ethyl-2-oxazoline) as new platforms for delivery of drugs with limited solubility.

Authors:  Bistra Kostova; Krasimira Ivanova-Mileva; Dimitar Rachev; Darinka Christova
Journal:  AAPS PharmSciTech       Date:  2013-01-17       Impact factor: 3.246

Review 3.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

4.  Synthesis and self-assembly of well-defined poly(amino acid) end-capped poly(ethylene glycol) and poly(2-methyl-2-oxazoline).

Authors:  Rodolphe Obeid; Carmen Scholz
Journal:  Biomacromolecules       Date:  2011-09-07       Impact factor: 6.988

5.  In vitro bio-immunological and cytotoxicity studies of poly(2-oxazolines).

Authors:  Juraj Kronek; Zuzana Kroneková; Jozef Lustoň; Ema Paulovičová; Lucia Paulovičová; Barbara Mendrek
Journal:  J Mater Sci Mater Med       Date:  2011-05-22       Impact factor: 3.896

6.  Protein modification with amphiphilic block copoly(2-oxazoline)s as a new platform for enhanced cellular delivery.

Authors:  Jing Tong; Robert Luxenhofer; Xiang Yi; Rainer Jordan; Alexander V Kabanov
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

7.  The bifunctional liposomes constructed by poly(2-ethyl-oxazoline)-cholesteryl methyl carbonate: an effectual approach to enhance liposomal circulation time, pH-sensitivity and endosomal escape.

Authors:  Huan Xu; Wei Zhang; Yan Li; Fei F Ye; Peng P Yin; Xiu Yu; Mei N Hu; Yuan S Fu; Che Wang; De J Shang
Journal:  Pharm Res       Date:  2014-05-08       Impact factor: 4.200

Review 8.  Poly(2-oxazoline)s as polymer therapeutics.

Authors:  Robert Luxenhofer; Yingchao Han; Anita Schulz; Jing Tong; Zhijian He; Alexander V Kabanov; Rainer Jordan
Journal:  Macromol Rapid Commun       Date:  2012-08-03       Impact factor: 5.734

Review 9.  Brain delivery of proteins via their fatty acid and block copolymer modifications.

Authors:  Xiang Yi; Alexander V Kabanov
Journal:  J Drug Target       Date:  2013-12       Impact factor: 5.121

10.  Poly(2-oxazoline)s as materials for biomedical applications.

Authors:  Victor R de la Rosa
Journal:  J Mater Sci Mater Med       Date:  2013-08-23       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.